The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Albers Jeffrey W. since year 2005.
The trader's CIK number is 1638474.
At the time of this reporting, Albers Jeffrey W. is the CEO and President of Blueprint Medicines Corp .
(stock ticker symbol BPMC).
See this page for all insider trading activities at Blueprint Medicines Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-06||BPMC||Blueprint Medicines Corp||Sale||30,000||71.26||2,137,800|
|2017-11-06||BPMC||Blueprint Medicines Corp||Option Ex||24,514||1.87||45,841|
|2017-08-07||BPMC||Blueprint Medicines Corp||Sale||20,000||48.75||975,000|
|2017-08-08||BPMC||Blueprint Medicines Corp||Sale||10,000||50.70||507,000|
|2017-06-28||BPMC||Blueprint Medicines Corp||Sale||20,000||50.18||1,003,540|
|2017-03-14||BPMC||Blueprint Medicines Corp||Sale||20,000||39.90||797,900|
|2016-08-08||BPMC||Blueprint Medicines Corp||Sale||17,000||23.03||391,510|
|2016-06-03||BPMC||Blueprint Medicines Corp||Sale||17,000||20.03||340,510|
|2016-04-06||BPMC||Blueprint Medicines Corp||Sale||17,000||20.42||347,140|
|2015-11-10||BPMC||Blueprint Medicines Corp||Sale||7,000||21.87||153,090|
|2015-11-02||BPMC||Blueprint Medicines Corp||Sale||10,000||21.02||210,200|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Albers Jeffrey W. (CEO and President of Blueprint Medicines Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.